Bishopbriggs man says new drug treatment will “change his life”

Source: The Press and Journal, March 2019

A new decision by NHS Scotland has meant that people with a rare form of cancer have the chance to forego radiotherapy in favour of tablets.

This month it was announced that the first oral BRAF-targeted treatment for post-surgery stage III melanoma patients, the most aggressive type of skin-cancer, was to be made available following approval by the Scottish Medicines Consortium (SMC).

Around 180 people die every year from melanoma in Scotland, and the number of people diagnosed has soared in recent years, with around 1,380 new cases every year.1

read the original full article